Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Tofacitinib may help regrow hair in alopecia areata patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Provenge extends prostate cancer survival by about 4 months.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Tofacitinib helped a woman regrow hair with no major side effects.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.